What Otago Innovation does

Otago Innovation Limited is the wholly-owned technology transfer and commercialisation subsidiary of the University of Otago, formed in 2003 and headquartered in Dunedin, New Zealand. The organisation operates exclusively with University of Otago researchers to translate early-stage academic discoveries into market-ready inventions, providing three structured funding programmes — the Activator Fund (up to NZ$50,000), the annual Proof of Concept Competition (NZ$100,000 prize), and the Advanced Projects Fund (NZ$120,000 to over NZ$1,000,000) — alongside intellectual property protection, commercialisation advisory, and investor-connection services delivered by an eight-person team of specialist commercialisation managers.

The business model is hybrid: services are delivered free of charge to University of Otago researchers, with the parent university and MBIE PreSeed Accelerator funding underwriting operating costs, while earned income is generated through licensing royalties, equity stakes in spin-out companies, and milestone payments. The current portfolio comprises approximately ten active startups and spin-off products spanning life sciences, biotech, medical devices, nutraceuticals, child development, and computational biology. Notable commercialisations include Amaroq Therapeutics (lncRNA cancer therapeutics, $14M raised in 2021 from Brandon Capital, NZ Innovation Booster, and CureKids Ventures), Chitogel (FDA-approved surgical hydrogel commercialised across NZ, US, Australia, and Europe), Dahlia4 (patented dahlia-extract nutraceutical partnered with Aroma New Zealand), ENGAGE (early-childhood self-regulation programme), and Redox Innovation (protein oxidation assay kit). Six additional early-stage technologies are currently available for licensing across cardiology, antimicrobials, industrial biotech, agritech, and neurology.

Distribution is principally direct and relationship-driven: commercialisation managers engage researchers across all University of Otago campuses, with supplementary channels including the annual Proof of Concept Competition, an investor access programme for select NZ and Australian investors, and partnerships with KiwiNet, Return on Science, Sprout, Polson Higgs, Ministry of Awesome, and Catalyst Intellectual Property. Geographic reach of the underlying commercialised products extends through licensees to Oceania, the Americas, and Europe, though Otago Innovation itself operates as a single-country domestic entity.

Name

Otago Innovation

Legal name

Otago Innovation Limited

Website

https://otagoinnovation.com

Company type

Private

Founded year

2003

Operating status

Operating

Headcount range

1–10 employees

Short description

Otago Innovation Limited is the University of Otago's wholly-owned technology transfer subsidiary, founded in 2003 and headquartered in Dunedin, New Zealand. It exclusively serves University of Otago researchers by providing funding programmes, IP protection, and commercialisation support to translate early-stage academic discoveries into market-ready spin-out companies and licensed technologies.

Ownership category

akta.pro rank

Product category

Technology Transfer Services

NAICS

Scientific Research and Development Services (5417)

SIC

Patent Owners & Lessors (6794)

akta.pro primary industry

Technology Transfer & Innovation-Driven Research Universities (High Commercialization) (EDAHABAH)

akta.pro secondary industry

IP Licensing, Transactions & Technology Transfer (BPAHAMAF)

Keywords

• Technology transfer services
• Research commercialisation
• University spinouts
• IP licensing
• Seed funding programmes

Headquarters

HQ city

Dunedin

HQ country

New Zealand

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Technology Transfer & Commercialisation Services: As a wholly-owned subsidiary of the University of Otago, Otago Innovation provides technology transfer services to researchers. Revenue is generated through successful commercialisation of university IP through licensing deals, equity in spin-out companies, and milestone payments from funded projects.
2. Funding Programs Management: Otago Innovation manages PreSeed Accelerator funding and distributes it to researchers through Activator Fund ($50K), Proof of Concept Competition ($100K), and Advanced Projects Fund ($120K+). They leverage MBIE and other government funding sources.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

Otago Innovation is the wholly-owned technology transfer and commercialisation subsidiary of the University of Otago. It provides University of Otago researchers with seed funding programmes, commercialisation advice, and intellectual property protection services, and converts qualifying research into protected IP, spin-out companies, and licensing deals. Revenue is recovered via equity stakes in formed spin-outs, licensing royalties, and patent monetisation.

Product overview

Otago Innovation is a technology transfer office and wholly-owned subsidiary of the University of Otago (established 2003) that helps university researchers commercialise their inventions. The organisation offers a portfolio of services including three structured funding programmes (Activator Fund up to $50K, Proof of Concept Competition with $100K prize, and Advanced Projects Fund up to $1M), intellectual property protection and commercialisation advisory services. The portfolio includes approximately 10 active startup companies and spinoff products such as Dahlia4 (nutraceutical), ENGAGE (child development programme), Amaroq Therapeutics (cancer therapeutics), Chitogel (medical device), and Redox Innovation's Protein Carbonyl Assay Kit. Currently, several early-stage technologies are available for licensing including VENTIMATE (asthma care), cardioprotective peptide, enzybiotic discovery platform, enzyme thermal stability estimator, F1 hybrid seed technology, and transcranial brain stimulation technology.

Differentiator

Problem solved

Functional benefit

Products and services

• Activator Fund
• Proof of Concept Competition
• Advanced Projects Fund
• Commercialisation Advice Service
• Intellectual Property Services
• Dahlia4 spin-out Active Otago Innovation spin-out company developing a skin cancer diagnostic device based on University of Otago research.
• ENGAGE spin-out Active Otago Innovation spin-out company operating in the digital wellbeing sector, originating from University of Otago research.
• Amaroq Therapeutics spin-out Active Otago Innovation spin-out company developing cancer therapeutics based on University of Otago research.
• Redox Innovation spin-out Active Otago Innovation spin-out company commercialising the Protein Carbonyl Assay Kit and related oxidative-stress diagnostic products based on University of Otago research.
• Chitogel spin-out Active Otago Innovation spin-out company commercialising Chitogel, a post-surgical adhesion barrier gel developed from University of Otago research.
• VENTIMATE licensable technology University of Otago-derived technology available for licensing through Otago Innovation.
• Cardioprotective peptide IP licensable technology University of Otago-derived cardioprotective peptide intellectual property available for licensing through Otago Innovation.
• Natural marine compound cancer treatment licensable technology University of Otago-derived natural marine compound technology for cancer treatment available for licensing through Otago Innovation.
• T-cell platform licensable technology University of Otago-derived T-cell platform technology available for licensing through Otago Innovation.
• Mealybug lure licensable technology University of Otago-derived mealybug lure technology available for licensing through Otago Innovation.

Quantifiable outcome

• $14 million investment raised for Amaroq Therapeutics spin-out
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Nine partnerships are on record, tiered core, major and supporting.

• Aroma New ZealandcoreOEM/ Whitelabel/ Licensing Partner · 1 January 2015Licensed and commercialised Dahlia4 research from University of Otago; Otago Innovation partnered with Aroma NZ to bring natural dahlia-extract supplement to market worldwide
• Ministry of Business Innovation & EmploymentcoreStrategic or Co-development PartnerGovernment ministry partnership providing strategic alignment and funding support for technology transfer activities and PreSeed Accelerator funding
• Return on SciencecoreStrategic or Co-development PartnerNational investment committee and funding initiative; Otago Innovation is a member contributing to investment decisions for biotech and pharma projects
• KiwiNetcoreStrategic or Co-development PartnerConsortium of New Zealand universities and CRI's focused on commercialisation; Otago Innovation participates on Emerging Innovator and Pipeline Committees; Dr Alex Tickle serves on these committees
• Methodist Mission SouthernmajorStrategic or Co-development PartnerKey collaborator in developing early childhood education version of ENGAGE self-regulation program; worked closely with Professor Dione Healey on adaptation within early childhood education settings
• SproutsupportingGTM or Marketing PartnerAgrifood accelerator programme providing $10,000 in-kind support for Proof of Concept Competition projects with applications in agrifood value chain through Germinate or Accelerator Programme
• Polson HiggssupportingImplementation/ SI/ Consulting PartnerAccounting firm providing $6,000 business advisory package to successful Proof of Concept Competition startup concept to ensure right commercial foundations
• Ministry of AwesomesupportingGTM or Marketing PartnerChristchurch-based innovation hub providing hot desk access for Christchurch applicants to Proof of Concept Competition for workspace and networking
• Catalyst Intellectual PropertysupportingImplementation/ SI/ Consulting Partner$7,000 value IP advice and strategy development support offered as additional prize in Proof of Concept Competition to help projects progress towards commercialisation

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Emerging players

• Sprout Agritech: NZ agritech accelerator and investment partner. Partnered with Otago Innovation on the Proof of Concept Competition ($10K in-kind prize for agrifood applicants). Comparable ecosystem player in the NZ commercialisation stack with shared researcher pipeline.
• WNT Ventures: NZ deep-tech accelerator and pre-seed fund focused on commercialising university and CRI research. Complementary rather than directly competitive, but operates in the same NZ pre-seed stack as Otago Innovation's funding programmes.

Direct peers

• AUT Ventures: Commercialisation arm of Auckland University of Technology. Comparable New Zealand TTO model serving AUT researchers with funding programmes, IP services, and spin-out formation. Operates in the same KiwiNet consortium and competes for the same MBIE PreSeed funding pool as Otago Innovation.
• Lincoln University (Research Commercialisation): Lincoln University runs its own research commercialisation function for agritech and land-based science. Comparable TTO model for a smaller NZ university, particularly relevant given Otago Innovation's F1 hybrid seed and agrifood licensing pipeline (Sprout partnership).
• Return on Science: NZ investment initiative and fund focused on early-stage commercialisation of university-derived science. Otago Innovation participates on its investment committees. Direct peer in the NZ pre-seed and seed capital stack for academic spin-outs.
• Auckland UniServices: The technology transfer and commercialisation office for the University of Auckland, New Zealand's largest university. Both organisations run the same playbook — wholly-owned subsidiary of a major NZ university, commercialisation managers engaging researchers, PreSeed funding, IP services, and spin-out equity. Direct head-to-head peer in the same national ecosystem.

Broad incumbents

• Oxford University Innovation: Technology transfer office for the University of Oxford. Operates the same fundamental model (researcher engagement, IP protection, spin-out formation, equity/royalty returns) at significantly greater scale. Useful as a benchmark for TTO operating leverage and portfolio maturity.
• Cambridge Enterprise: University of Cambridge's commercialisation arm. Comparable TTO model with structured funding programmes, IP services, and a deep portfolio of biotech, deep-tech, and therapeutics spin-outs. Direct functional peer at significantly larger scale.
• Kiwi Innovation Network (KiwiNet): Consortium of NZ universities and CRIs focused on research commercialisation. Otago Innovation is a member and Dr Alex Tickle sits on its Emerging Innovator and Pipeline Committees. KiwiNet is the broader ecosystem body that aggregates TTO outputs nationally.

Others

• Brandon Capital Partners: Australasian life-sciences venture firm that led the $14M Amaroq Therapeutics round. CEO David Christensen sits on its Australasian committee. An investor/partner rather than competitor, but central to Otago Innovation's biotech deal-flow.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles10 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments2 records

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Otago Innovation